BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15118756)

  • 1. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
    Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
    Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas.
    Hirao S; Yamada Y; Koyama F; Fujimoto H; Takahama Y; Ueno M; Kamada K; Mizuno T; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Nakajima Y
    Cancer Gene Ther; 2002 Aug; 9(8):700-7. PubMed ID: 12136432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
    Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
    J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX; Yuan SZ; Nakamura T
    Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
    Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
    Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice.
    Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H
    Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppression of peritoneal implantation by NK4 and its mechanisms].
    Atsuji K; Fujiwara H; Kubota T; Inada S; Takashima K; Yoshimura M; Ueda Y; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1777-9. PubMed ID: 15553712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.
    Fujiwara H; Kubota T; Amaike H; Inada S; Takashima K; Atsuji K; Yoshimura M; Maemondo M; Narumi K; Nukiwa T; Matsumoto K; Nakamura T; Hagiwara A; Yamagishi H
    Cancer Gene Ther; 2005 Feb; 12(2):206-16. PubMed ID: 15486556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation.
    Yoshimura M; Fujiwara H; Kubota T; Amaike H; Takashima K; Inada S; Atsuji K; Araki Y; Matsumoto K; Nakamura T; Yamagishi H
    Anticancer Res; 2005; 25(6B):3847-54. PubMed ID: 16309170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival.
    Saga Y; Mizukami H; Suzuki M; Urabe M; Kume A; Nakamura T; Sato I; Ozawa K
    Gene Ther; 2001 Oct; 8(19):1450-5. PubMed ID: 11593357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
    Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
    Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
    Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Biochem Biophys Res Commun; 2007 Jun; 358(1):117-23. PubMed ID: 17467663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.